Global Meningococcal Vaccines Market Size, Trends & Growth Opportunity By Vaccine Serotype (MenAC, MenA, MenC, MenB & Manic, and MenACWY), By Vaccine Type (Subcapsular, Polysaccharide, and Conjugate), By End User Channel (Adult, Pediatric, and Travelers), By Region and Forecast till 2027
Market Overview
Global Meningococcal Vaccines Market was valued at 3.0 billion in 2021 which is expected to reach USD 4.95 billion by 2027 at CAGR 8.41 %from 2022-2027.
Fungi, bacteria, and viruses can all cause meningitis. Meningococcal meningitis is a bacterial form of meningitis caused by the bacterium Neisseria meningitides (meningococcus). Meningococcal meningitis is prevented with the use of meningococcal vaccinations. 
Market Drivers
The increase in the number of reportable cases of meningococcal meningitis in the Sub-Saharan African region is the primary driving factor projected to promote the worldwide meningococcal vaccines market growth. For example, according to a World Economic Forum report, 37.4 million tourists visited Sub-Saharan Africa in 2018. Furthermore, an increase in government awareness initiatives, as well as an increase in government interventions in refining healthcare infrastructure, will positively benefit the worldwide meningococcal vaccines market. Furthermore, an increase in meningococcal vaccine research and development efforts is likely to drive the worldwide meningococcal vaccines market growth.
Market Restraints
Stringent government norms and regulations for approval, on the other hand, are projected to stymie the worldwide meningococcal vaccines market growth. Furthermore, the recall of numerous products owing to contamination would have an impact on the worldwide meningococcal vaccines market growth.
Market Segmentation
Global Meningococcal Vaccines Market is segmented into vaccine serotype such as MenAC, MenA, MenC, MenB & Manic, and MenACWY, by vaccine type such as Subcapsular, Polysaccharide, and Conjugate. Further, Global Meningococcal Vaccines Market is segmented into end user such as Adult, Pediatric, and Travelers.
Also, Global Meningococcal Vaccines Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the Meningococcal Vaccines market. Favorable government recommendations and support, as well as significant R&D investments, are some of the drivers driving the North America market. Furthermore, a well-developed healthcare infrastructure and increased awareness campaigns in the region are expected to drive market growth.
Market Key Players
Various key players are discussed in this report such as Serum Institute of India Pvt. Ltd, Emergent BioSolutions, Inc, Sanofi, Merck & Co., Inc, GlaxoSmithKline, plc, and Pfizer Inc.
Market Taxonomy
By Vaccine Serotype
• MenAC
• MenA
• MenC
• MenB & Manic
• MenACWY
By Vaccine Type
• Subcapsular
• Polysaccharide
• Conjugate
By End User
• Adult
•  Pediatric
•  Travelers
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Global Meningococcal Vaccines Market TOC 
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Meningococcal Vaccines Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Meningococcal Vaccines Market, By Vaccine Serotype
5.1 Y-o-Y Growth Comparison, By Vaccine Serotype 
5.2 Global Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype 
5.3 Global Meningococcal Vaccines Market Size and Forecast, By Vaccine Serotype
5.3.1 MenAc
5.3.2MenA
5.3.3 MenC
5.3.4 MenB & Manic
5.3.5MenACWY
6 Global Meningococcal Vaccines Market, By Vaccine Type
6.1 Y-o-Y Growth Comparison, By Vaccine Type
6.2 Global Meningococcal Vaccines Market Share Analysis, By Vaccine Type
6.3 Global Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
6.3.1 Subcapsular
6.3.2 Polysaccharide
6.3.3 Conjugate
7 Global Meningococcal Vaccines Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Meningococcal Vaccines Market Share Analysis, By End User
7.3 Global Meningococcal Vaccines Market Size and Forecast, By End User
7.3.1 Adult
7.3.2 Paediatric
7.3.3 Travelers
8Global Meningococcal Vaccines Market, By Region
8.1 Global Meningococcal Vaccines Market Share Analysis, By Region
8.2 Global Meningococcal Vaccines Market Share Analysis, By Region
8.3 Global Meningococcal Vaccines Market Size and Forecast, By Region
9 North America Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 North America Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
9.3 North America Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
9.4 North America Meningococcal Vaccines Market Size and Forecast, By End User
9.5 North America Meningococcal Vaccines Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10Europe Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Europe Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype 
10.3 Europe Meningococcal Vaccines Market Size and Forecast, By Vaccine Type 
10.4 Europe Meningococcal Vaccines Market Size and Forecast, By End User
10.5 Europe Meningococcal Vaccines Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Asia Pacific Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype 
11.3 Asia Pacific Meningococcal Vaccines Market Size and Forecast, By Vaccine Type 
11.4 Asia Pacific Meningococcal Vaccines Market Size and Forecast, By End User
11.5 Asia Pacific Meningococcal Vaccines Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Latin America Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype 
12.3 Latin America Meningococcal Vaccines Market Size and Forecast, By Vaccine Type 
12.4 Latin America Meningococcal Vaccines Market Size and Forecast, By End User
12.5 Latin America Meningococcal Vaccines Market Size and Forecast, Country
13Middle East Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
13.1 Introduction
13.2 Middle East Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype 
13.3 Middle East Meningococcal Vaccines Market Size and Forecast, By Vaccine Type 
13.4 Middle East Meningococcal Vaccines Market Size and Forecast, By End User
13.5 Middle East Meningococcal Vaccines Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Serum Institute of India Pvt. Ltd
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Emergent BioSolutions, Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Sanofi
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Merck & Co., Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 GlaxoSmithKline, plc
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Pfizer Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies